Aethlon Medical (NASDAQ:AEMD) Coverage Initiated by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Aethlon Medical (NASDAQ:AEMD) in a report issued on Tuesday morning. The brokerage issued a sell rating on the medical equipment provider’s stock.

Separately, HC Wainwright reaffirmed a “buy” rating and set a $7.00 target price on shares of Aethlon Medical in a research note on Friday, November 15th.

Aethlon Medical Price Performance

NASDAQ:AEMD opened at $0.38 on Tuesday. Aethlon Medical has a 52 week low of $0.24 and a 52 week high of $2.35. The stock’s fifty day moving average is $0.40 and its two-hundred day moving average is $0.42. The company has a market capitalization of $5.29 million, a P/E ratio of -0.13 and a beta of 1.79.

About Aethlon Medical

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.